Product ID: SQSG35A2019
Report ID:
SQSG35A2019 |
Region:
Global |
Published Date: April, 2024
Pages:
165
|
Tables:
66 |
Figures:
75
Regarding the women's health devices market's competitive environment, there are numerous businesses of varying sizes present, each with a varied product portfolio and a broad range of potential applications. F. Hoffmann-La Roche Ltd. currently holds a dominant position in the market, mostly as a result of the company's diagnostics portfolio, which includes several products that address female health issues. Numerous female cancers, as well as pregnancy and fertility, are some of the application areas of women's health that F. Hoffmann-La Roche Ltd. handles. Boston Scientific Corporation is another significant competitor with a big array of medical devices for pelvic health.
Due to their product offerings focused on female urinary incontinence and diagnostics, other businesses like Coloplast A/S and Hologic Inc. also hold a significant market share of the global market. Several rising businesses are anticipated to emerge as a result of increased investment activities in the women's health devices market, and these businesses may grow their market shares during the forecast period.
Top Players in the Global Women’s Health Devices Market
Women's Health Devices Market Recent Development
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONGlobal Women's Health Devices Market size was valued at USD 38.43 billion in 2019 and is poised to grow from USD 40.29 billion in 2023 to USD 468.18 billion by 2031, growing at a CAGR of 4.8% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQSG35A2019